戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  fluralaner (Bravecto, presently sold as the racemate).
2 city of its residues relative to that of the racemate.
3 orm of a chiral compound is favored over its racemate.
4 entadienyl anion that detrimentally yields a racemate.
5  formation of an inversion center for an NCS racemate.
6  promote the background reaction to form the racemate.
7 igher than those of S-(-)[2-13C]equol or the racemate.
8  breaking induced by an achiral surface in a racemate.
9 o successive evaporations to precipitate the racemate.
10 attributable to a specific enantiomer in the racemate.
11  stability at room temperature, favoring the racemate.
12 butyric acid and norvaline, were found to be racemates.
13 differences in Vss were observed between the racemates.
14  6 were twice as potent as the corresponding racemates.
15 s are abundant in nature but rarely occur as racemates.
16 ously through dynamic kinetic resolutions of racemates.
17 to design a resolution screen for six unseen racemates.
18 tural product families are reported as their racemates.
19 oselectively resolve 6 additional amino acid racemates.
20 on between those of the conglomerate and the racemates.
21 th the assembly in the solid-state, even for racemates.
22 reater potency than the other three possible racemates.
23 roarrhythmic activity than the corresponding racemates.
24 erences observed between enantiomers and the racemates.
25               A PLK4 X-ray co-structure with racemate 18 revealed preferential binding of the 1R,2S e
26                                 Three active racemates (20, 22, 25) were separated into the enantiome
27                                Separation of racemate 30 afforded 32, the R enantiomer, which demonst
28 tions of compound 41 (the decanoate ester of racemate 32) eliminated cocaine-maintained behavior for
29 finities of the enantiomers 8 and 12 and the racemate 4 at guinea pig, rat, and cloned human A1- and
30 630 +/- 140 microM) was more potent than the racemate 6 (IC50 = 730 +/- 88 microM) while the R-isomer
31 -methyltetrahydrofolic acid (5-MTHF) and its racemate [6R,S] form was made by TEAC assay at different
32 enoid biosynthesis, is currently marketed as racemate against dicotyledonous weeds in cereals.
33  chiral soil herbicide currently marketed as racemate against dicotyledonous weeds in cereals.
34 ere approved between 2013 and 2022, one as a racemate and one as a single enantiomer.
35 erts spontaneously to the former, which is a racemate and showed cell protection against RIPs.
36    The ability of TZF to simultaneously form racemate and solid solution originates from its conforma
37  why preuisolactone A has been isolated as a racemate and suggests that the natural product is not a
38 re more potent than their S counterparts and racemates and (R)-2 was more efficient than (R)-1 and th
39 al medicines, 1,591 (74%) and 559 (26%) were racemates and single active enantiomers, respectively.
40           The discovery of many more natural racemates and their potential enzymatic sources in recen
41 high affinity for VAChT (Ki = 0.93-18 nM for racemates) and moderate to high selectivity for VAChT ov
42 y in hemoglobin solutions than its antipode, racemate, and RSR13.
43 matic and non-enzymatic formation of natural racemates, and their pharmacological significance.
44                   Fluid phase separations of racemates are difficult because the subtle, short-ranged
45  bias (data available only for systems whose racemates are stable enough to exist) and a possible kin
46                       Initial studies with a racemate at 1.85 A resolution failed to identify the chi
47 ed from thalidomide is developed and sold as racemates because of racemization at the chiral center o
48                Potential substitution of the racemate by (-)-beflubutamid should therefore be further
49 or instance, the resolution of some helicene racemates by "hand picking" of a few homochiral single e
50 rowth rate compared to that of the competing racemate (by 4- to 40-fold between 80 and 146 degrees C)
51           Therapeutics developed and sold as racemates can exhibit a limited therapeutic index becaus
52 lative stability of the conglomerate and the racemate changes with the molecule's degree of chirality
53 theses represent a diastereomeric mixture or racemate; compound numbers without parentheses represent
54 rackets represent diastereomeric mixtures or racemates; compound numbers without brackets represent e
55 ally useful stereopromiscuity toward a toxic racemate, concomitant with high catalytic efficiency and
56 enriched to near optical purity by selective racemate crystallization.
57 tors favor conglomerate crystallization over racemate crystallization.
58                                              Racemates crystallize as the solid solution of enantiome
59 nomalous dispersion (MAD) phasing from quasi-racemate crystals was then used to determine the X-ray s
60 whole class of single-species systems, i.e., racemate crystals, might possess NN CD-ee dependence and
61 cages with BF(4) (-) as counterions afforded racemate crystals; while crystallizations of cages with
62                                    Even as a racemate, DAG-lactone 31 showed low namomolar binding af
63 re rapidly identified, and resolution of the racemate demonstrated that only the R-enantiomer display
64 e excess energy of the conglomerate over the racemate, (E(C) - E(R)), increases with the size of the
65 A comparison of enantiomeric haptens and the racemate elucidated the importance of employing (S)-ster
66 ide (SR141716) was nearly double that of the racemate for the same determination; therefore, the acti
67 orm had higher antioxidant activity than its racemate form in the TEAC assay at all pHs, with similar
68 ctive formation of a C60 fullerene bisadduct racemate from a complex mixture of 130 bisadducts.
69     All target compounds were synthesized as racemates from 1,3-dihydroxy-2-propanone.
70 ess free energy of the conglomerate over the racemate, (G(C) - G(R)), shows no simple relation with t
71 emical properties of both SubPc-TCBD-aniline racemates have been investigated using a wide range of e
72                                              Racemates have recently received attention as nonlinear
73  linkers seemed to impart antagonism even as racemates; however, the potency of these analogues in th
74 method to isolate enantiopure molecules from racemates if enantiomers self-sort into separate enantio
75 gical activities of both enantiomers and the racemate in field trials showed that the (S)-(+)-enantio
76 iracemate, which is then treated like a true racemate in successive steps of the synthesis.
77 molecular interactions on the assembly of Cu racemates in the CS and NCS structures.
78 ined the effect of inclusion or exclusion of racemates in the partial least squares (pls) analysis.
79 ing of assembly processes of enantiomers and racemates, in both dilute solution and concentrated gels
80 separation of enantiomers of a wide range of racemates including pharmaceuticals, amino acids, and ca
81  provided the chiral resolution of around 20 racemates, including drugs, illegal drugs, amino-acids,
82 nable the selective permeation of a range of racemates, including mandelic acid (Man), Fmoc-phenylala
83 e scaffold allowed for the separation of the racemate into single enantiomers that proved to be therm
84 ive concentration of agonist 4-fold, and the racemate is brain-penetrant.
85 ing a structural phase transition, while the racemate is mechanically inactive.
86 linking the absence of inversion symmetry in racemates is presented for all NCS crystal classes.
87        The occurrence of natural products as racemates is very intriguing from a biosynthetic point o
88 ssembly of mixtures of enantiomer (including racemates) is nontrivial.
89 Zr, Hf) system, the polar noncentrosymmetric racemate (M-NCS) forms in competition with a centrosymme
90 nough to exist) and a possible kinetic bias (racemates may be easier to crystallize than conglomerate
91                                   The use of racemates may cause harm to the public and may contribut
92 ystallization of achiral precursors yielding racemate metal organic frameworks/coordination polymers
93 s of chiral molecules tend to aggregate into racemate (molecularly heterochiral) crystals much more f
94 pon mixing 26% of (M)-heptahelicene into the racemate monolayer, only the (M)-pentahelicene enantiomo
95 pe fibrinogen receptor antagonist RWJ-50042 (racemate of 1), which was derived from a unique approach
96 icate racemic mixtures; thus (3b+3b') is the racemate of 3b and 3b'), and tripeptide 13 were synthesi
97 show that preparing a cage starting from the racemate of a shorter bis-monodentate ligand derivative,
98               Recently, the synthesis of the racemate of an overcrowded triply fused carbo[7]helicene
99  enantiopure oxiranylpropargylic ester 13, a racemate of cyclopentenone (R*,S*)-16 was obtained.
100            Additionally, the enantiomers and racemate of each metabolite were assayed for inhibition
101 o pure enantiomers of petrocortyne A and the racemate of its diastereomer.
102                                            A racemate of two opposite and resolvable enantiomers is g
103 ituted quinolizidines (207I (IV), 233A (V)), racemates of alkaloids found in the skins of neotropical
104 dual enantiomers and racemates, we find that racemates of carboxamide, thioamide, and their combinati
105                                              Racemates of five chiral resorcin[4]arenes, four tetra-O
106                                              Racemates often have lower solubility than enantiopure c
107                Adsorption of a pentahelicene racemate on a Au(111) surface leads to 2D conglomerate c
108 s no interaction between the DD-LL and DL-LD racemates on any length scale from the macroscopic to th
109  numbers written within brackets represent a racemate or a diastereomeric mixture; compound numbers w
110 hibited greater biological activity than the racemates or (+)-isomers.
111 ting PROTACs are synthesized as a mixture of racemates or diastereomers.
112 ves with a stoichiometry of two molecules of racemate per enzyme flavin.
113 pai-pai interactions between the adjacent Cu racemates preclude an inversion center.
114                   Strategies for suppressing racemate-producing, off-catalyst pathways have long focu
115               Very good separations of model racemate (R,S)-N-3,5-dinitrobenzoylleucine were achieved
116 lta and S-Delta in ClCH2CH2Cl are mixed, the racemate rac-Delta forms an organogel that is composed o
117  usually crystallizes as a racemic compound (racemate), rarely as a conglomerate, and even more rarel
118 ates a tendency for chiral molecules to form racemates rather than conglomerates.
119 ai stacking interactions between adjacent Cu racemates regardless of cation geometries, hydrogen bond
120 oselectivity toward primary amine-containing racemates, separating 98% of those tested.
121                   The EMA has not approved a racemate since 2016, while the average for the FDA is on
122  information on the chirality status (either racemates, single active enantiomer or achiral) of medic
123       This is the first example of a protein racemate that crystallized in space group I41/a.
124 e-bridged phenylmorphans, all but two of the racemates, the ortho- and para-b-oxide-bridged phenylmor
125  deracemization method for conversion of the racemate to the desirable (R)-enantiomer of Praziquantel
126  prepared by resolution of the corresponding racemates, using the lipase formulation Novozyme 435.
127                          A 3R,4R,5R/3S,4S,5S racemate was found to have greater potency than the othe
128  crystallized, and the structure of the true racemate was solved at a resolution of 2.7-2.15 A.
129 separation of dihydropyrimidinone (DHP) acid racemate was studied for the first time by quasi-equilib
130 solution of cationic (77%) and neutral (85%) racemates was very high.
131 ion propensity of individual enantiomers and racemates, we find that racemates of carboxamide, thioam
132       Remarkably, these modes of assembly of racemates were also retained in solid-state.
133             The best model was obtained when racemates were excluded from QSAR analysis.
134        The most potent H4R agonists among 14 racemates were separated by chiral HPLC, yielding eight
135 e compounds, which have been all isolated as racemates, were unambiguously characterized by (1)H and
136 icient to predict whether the multimolecular racemate will or will not segregate.
137  optical purity by optical resolution of the racemate with the camphoric acids.
138 er (asymmetric carbon) are mainly present as racemates with a mixture of equal amounts of enantiomers
139                            The proportion of racemates within chiral medicines was considerably highe

 
Page Top